[Immune status of hemophilia patients treated with blood preparations: laboratory and clinical assessment (review of the literature)].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to V P Rudenko.
Explore the source record for details and available documents.
Hemophiliac patients develop disorders of the immune status as a result of transfusion therapy: a decrease in the number of T-lymphocytes and the ratio T-helpers/T-suppressors resulting from a decrease in the number of T-helpers, enhancement of immunoglobulinogenesis, and an increase in the level of circulating immune complexes. A degree of the above changes depends on a dose and period of the use of antihemophilic drugs. Hemophiliac patients require immunological monitoring, clinical substantiation of doses and a prolonged period of administration of blood preparations.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Results are analyzed of a clinical observation and examination of 188 patients with haemophilia aged 10-77 years. The haemophilia patients were diagnosed as having developed secondary immunodeficiency related to chronic antigenic stimulation of the patient's immune system by allogenic proteins which contain plasma preparations. Against the background of immunodeficiency, there occur in the patients complications of immune character such as appearance of immune inhibitors to clotting factors. The authors are of the opinion that the nature of the inhibitory form of haemophilia is related, first, to genetic anomalies in factor VIII (IX), which cause the development of the autoimmune process; second, that as a result of alloimmunization and immunomodulating action of substitution therapy there develop persistent disorders in immunoregulation and activation of antibody genesis, which facts come to trigger off the appearance of inhibitory antibodies.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.